2023 | Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
| TRANSLATIONAL LUNG CANCER RESEARCH |
2019 | Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
| YONSEI MEDICAL JOURNAL |
2022 | Real-world clinical features, health-care utilization, and economic burden in decompensated cirrhosis patients: A national database | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
| FRONTIERS IN ONCOLOGY |
2023 | Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset
| FRONTIERS IN ONCOLOGY |
2023 | Real-World Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in the Era of Current-Generation Devices
| JOURNAL OF CLINICAL MEDICINE |
2017 | Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients
| KOREAN CIRCULATION JOURNAL |
2023 | Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism
| BMC MEDICINE |
2023 | Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from Korea | HAEMOPHILIA |
2023 | Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
| BLOOD CANCER JOURNAL |
2022 | Real-world data on prevalence of MSI-H/dMMR across 6 solid tumor types in Asia | ANNALS OF ONCOLOGY |
2022 | Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma | BRITISH JOURNAL OF HAEMATOLOGY |
2021 | Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2019 | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | GYNECOLOGIC ONCOLOGY |
2022 | Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea
| VIRUSES-BASEL |
2022 | Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2019 | Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2021 | Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2020 | Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study | JOURNAL OF HYPERTENSION |
2022 | Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
| ESC HEART FAILURE |